| [1] |
ZHANG Yidan, SUN Xinghua, QU Yang, HU Xiaoyang, ZHANG Miao.
Research progress on the regulation of PI3K/Akt signaling pathway by active ingredients of traditional Chinese medicine in the treatment of cerebral ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 820-827.
|
| [2] |
DING Ding, WU Shengnan, WANG Ancai, WANG Deguo.
Research progress on the inhibition of cardiac remodeling by vericiguat
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 858-863.
|
| [3] |
LIU Yeyuan, QI Yafeng, ZHANG Maofu, LI Xinyu, SHEN Yanyun, LIU Yu, ZHANG Shangzu, LI Yangyang, ZHANG Liying, ZHANG Zhiming.
Research progress of traditional Chinese medicine intervention in chemotherapy renal injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 556-569.
|
| [4] |
LIU Xuan, FENG Cuijuan, WANG Yiqiang, LI Fang.
Research progress of miRNA in ulcerative colitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 917-929.
|
| [5] |
ZHAO Quanming, YANG Mandou, HU Yibo, SU Youtong, PU Li, ZHANG Yu, LI Wenliang.
Research progress on drug treatment and drug resistance mechanism of gastrointestinal stromal tumors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 82-89.
|
| [6] |
XU Jinhui, YUE Hongmei, LI Yating, LIU Miaomiao, WU Xingdong, ZHU Haobin.
Advances in the study of mesenchymal stem cells in obstructive sleep apnea hypoventilation syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 114-120.
|
| [7] |
LUO Shiping, ZHANG Jie, YU Yushuai, SONG Chuangui.
Advances in targeted therapy for HER2-positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 876-886.
|
| [8] |
ZHANG Li, LIN Xingyao, SHANG Yun, WANG Qiang.
Progress on the pathological mechanism and treatment of frostbite
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 347-354.
|
| [9] |
LI Chenhao, YU Xihua, YAN Wenhao, CHAI Yuxia, LI Yanyan, LI Kun, LI Zeyun.
Research progress on the relationship between pediatric epilepsy and vitamin D
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1299-1306.
|
| [10] |
LIU Dan, LIU Ming, JIN Liangyou, PAN Juan, XIN Haoru, LIU Mengyuan, LI Xin, ZHENG Kun, FENG Xiaoling.
Research progress on the antitumor activity of costunolide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1168-1176.
|
| [11] |
LI Miao, YU Qinwei, JIANG Zhenzhou, ZHANG Luyong, .
Regulatory mechanism of LDLR and research progress of its related diseases and drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 946-954.
|
| [12] |
CHEN Wenjie, WANG Yabing, CHEN Xiaolin, REN Junling, ZHAO Wanjun, CHEN bin.
Advances in the study of iodine-resistant differentiated thyroid cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 116-120.
|
| [13] |
HAO Haiping.
Metabolic regulation and drug target discovery researches in China: Progress and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 955-963.
|
| [14] |
CHEN Ying, YUAN Yonggui.
Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
|
| [15] |
PEI Qinghua, SUN Jianli.
Research progress of Osimertinib acquired resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 105-112.
|